[title]
[author]
[shortEnglishNames]
[pubIssue]
DOI:
[Doi]
(PDF [paperSize]K)
[HTML] [XML]
Back
Home
Submission
Articles
Journals
Book
Services
Blog
Back
Search
Menu
Sign in
Journals by Subject
Journals by Title
Search
Evaluation of Safety and Efficacy of Glaritus
®
versus Lantus
®
in Combination with Insulin Lispro among Adults with Type 1 Diabetes Mellitus-Phase IV Study
Gaurav Puppalwar,
Sandesh Sawant,
Bhimsen Silgiri,
Kirti Shukla,
Hanmant Barkate
Open J. Endocr. Metab. Dis.
Vol.7 No.4, April 30, 2017
DOI:
10.4236/ojemd.2017.74011
(PDF 907K)
HTML
XML
Immunogenicity, Safety and Efficacy Comparison of Wockhardt’s Biosimilar Insulin Glargine—Glaritus® with Reference Product— Lantus®: Study Protocol & Early Data Trends
S. K. Sharma,
A. K. Ajmani,
P. Khosla,
P. Mukhopadhyay,
G. Bhatia,
K. G. Prakash,
G. Chhaya,
P. D. Supe,
V. Pavithran,
H. Bora,
R. Jain,
S. Ingole,
A. Shah
Open J. Endocr. Metab. Dis.
Vol.8 No.8, August 30, 2018
DOI:
10.4236/ojemd.2018.88016
(PDF 265K)
HTML
XML
Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection
Mark R. Burge,
Eric R. Schroeder,
Stephen Mitchell
J. Diabetes Mellit.
Vol.2 No.2, May 25, 2012
DOI:
10.4236/jdm.2012.22032
(PDF 301K)
HTML
XML
Iowa medicaid 2: lapse of glycemic control on abrupt transition from insulin glargine to insulin detemir in type 2 diabetes mellitus
Udaya Kabadi
J. Diabetes Mellit.
Vol.1 No.4, November 08, 2011
DOI:
10.4236/jdm.2011.14017
(PDF 82K)
HTML
Efficacy and Safety of Patient-Led Dosage Adjustments of Insulin Glargine: A Preliminary Report of Basal-Supported Oral Therapy for Japanese Type 2 Diabetes Patients
Shuhei Nakanishi,
Mitsunobu Kubota,
Rui Kishimoto
J. Diabetes Mellit.
Vol.4 No.2, April 21, 2014
DOI:
10.4236/jdm.2014.42014
(PDF 363K)
HTML
About SCIRP
|
Sitemap
|
News
|
Jobs
Full Site
Copyright © 2020 Scientific Research Publishing Inc. All Rights Reserved.
Top